Abstract

NADC34-like porcine reproductive and respiratory syndrome virus (PRRSV) has been circulating in China for several years and became the dominant field strain in some provinces. Current commercial vaccines could not provide complete cross-protection to NADC34-like PRRSV infection, which led to huge economic losses on pig farms. Co-infections of NADC34-like PRRSV with some other PRRSV strains are commonly found in many clinical cases, and successful isolation of NADC34-like PRRSV strain from the clinical samples has been a challenge to study its biological characters and perform animal experiments to evaluate its pathogenicity. In this study, we constructed a NADC34-like PRRSV infectious clone derived from the isolated JS2021NADC34 PRRSV strain using the reverse genetics technique and investigated its virulence and pathogenicity for nursery pigs. The rescued (rNADC34) strain could proliferate well in porcine alveolar macrophages (PAMs), and the viral copy number and titers were comparable to parental strain. For pathogenicity, the rNADC34 strain-infected pigs showed high body temperature and body weight loss. The histopathological results presented interstitial pneumonia and severe hemorrhage, infiltration of neutrophils and lymphocyte in lungs, lymph nodes, and tonsils. The viral proteins were also detectable in rNADC34 strain-infected pigs using immunohistochemistry staining. Moreover, the trends of PRRSV-specific antibody and viremia in PRRSV rNADC34-infected pigs were similar with the parental strain-infected pigs. These data indicated that rNADC34 strain manifested strong virulence and high pathogenicity for nursery pigs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.